Li Minmin, Song Yanbo, Li Longhao, Qin Jian, Deng Hongbin, Zhang Tao
Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Front Oncol. 2021 Nov 26;11:780581. doi: 10.3389/fonc.2021.780581. eCollection 2021.
Whole brain radiotherapy (WBRT) for brain metastases (BMs) was considered to be dose limited. Reirradiation of WBRT for recurrent BM has always been challenged. Here, we report a patient with multiple BMs of non-small-cell lung cancer (NSCLC), who received two courses of WBRT at the interval of 5 years with the cumulative administration dose for whole brain as 70 Gy and a boost for the local site as 30 Gy. Furthermore, after experiencing relapse in the brain, he underwent extra gamma knife (GK) radiotherapy for local brain metastasis for the third time after 5 years. The overall survival was 12 years since he was initially diagnosed with NSCLC with multiple brain metastases. Meanwhile, each time of radiotherapy brought a good tumor response to brain metastasis. Outstandingly, during the whole survival, he had a good quality of life (QoL) with Karnofsky Performance Score (KPS) above 80. Even after the last GK was executed, he had just a mild neurocognitive defect. In conclusion, with the cautious evaluation of a patient, we suggest that reirradiation of WBRT could be a choice, and the cumulative radiation dose of the brain may be individually modified.
全脑放疗(WBRT)用于脑转移瘤(BMs)时被认为存在剂量限制。对复发性BM进行WBRT再程放疗一直面临挑战。在此,我们报告1例非小细胞肺癌(NSCLC)多发BM患者,其在5年的间隔期内接受了两个疗程的WBRT,全脑累积给药剂量为70 Gy,局部部位追加剂量为30 Gy。此外,在脑部复发后,他在5年后第三次接受了针对局部脑转移瘤的伽玛刀(GK)放疗。自最初诊断为NSCLC伴多发脑转移以来,其总生存期为12年。同时,每次放疗均使脑转移瘤产生良好的肿瘤反应。值得注意的是,在整个生存期内,他的生活质量(QoL)良好,卡氏功能状态评分(KPS)高于80分。即使在最后一次GK放疗后,他也仅有轻度神经认知缺陷。总之,经过对患者的谨慎评估,我们认为WBRT再程放疗可以作为一种选择,且脑部的累积放疗剂量可进行个体化调整。